Importantly, increased Gal3 levels have also been observed in AD patients’ brains and CSF (Boza-Serrano et al., 2019; Boza-Serrano et al., 2022), demonstrating an interesting correlation with the human pathology. Here, LGALS3 is linked to Alzheimer disease.